Radioactive drug takes aim at Hard-to-Treat sarcoma
Disease control
Recruiting now
This early-phase trial is testing a radioactive drug called [Ac225]RTX-2358 in 30 adults with advanced soft tissue sarcoma that has come back or stopped responding to prior treatment. The drug is given as an IV injection once every 8 weeks for up to 6 doses. The main goals are to…
Phase: PHASE1 • Sponsor: Ratio Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC